Skip to content
DataLookout
Menu

NCT07280429

Baduanjin Rehabilitation for Functional Restoration in ICI-Associated Myocarditis

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Recruitment opened Show 5 more changesShow less
    • Primary endpoint(s) modified
    • Start date: Jan 1, 2026 to Dec 2026
    • Eligibility criteria expanded, about 19 words
    • Study sites: 0 to 1
    • Study title revised
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

MACE
Timeframe: 2 weeks
NT-proBNP/BNP levels
Timeframe: 2 weeks
Change in EuroQol Visual Analogue Scale (EQ VAS) Score
Timeframe: 2 weeks

Secondary (1)

MACE

Arms and interventions

Rehab ArmExperimental

The pharmacological rehabilitation protocol consists of oral administration of Shengxian Quyu Decoction. The traditional Chinese exercise rehabilitation protocol is designed following the FITT (Frequency, Intensity, Time, Type) principles of exercise therapy. Exercise modalities may include Baduanjin, with specific frequency, duration, and intensity tailored to each participant's actual condition. The total treatment period is 2 weeks.

Control ArmNo intervention

The control arm received conventional treatment.

Other: rehabilitation protocol

Sites

1 site in 1 country

  • China-Japan Friendship HospitalBeijing, Beijing Municipality, China